Benjamin J. Zeskind
First SEC filing: July 29, 2021 · Latest: Feb. 10, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 23, 2026 | IMRX | P | 2,400 | $4.56 | $10,944 | 2,315,252 Direct | +0.10% | Acquired | -11.4% (price as of 2026-10-05) |
| Feb. 3, 2026 | IMRX | A | 688,000 | · | · | 688,000 Direct | · | Acquired | (price as of 2026-10-05) |
| July 2, 2025 | IMRX | P | 7,015 | $3.53 | $24,763 | 2,312,852 Direct | +0.30% | Acquired | 14.4% (price as of 2026-10-05) |
| July 1, 2025 | IMRX | P | 2,985 | $3.38 | $10,089 | 2,305,837 Direct | +0.13% | Acquired | 19.5% (price as of 2026-10-05) |
| June 18, 2025 | IMRX | P | 21,000 | $2.39 | $50,190 | 2,302,852 Direct | +0.92% | Acquired | 69.0% (price as of 2026-10-05) |
| Feb. 5, 2025 | IMRX | A | 480,000 | · | · | 480,000 Direct | · | Acquired | (price as of 2026-10-05) |
| March 19, 2024 | IMRX | P | 20,000 | $2.77 | $55,400 | 2,281,852 Direct | +0.88% | Acquired | 45.8% (price as of 2026-10-05) |
| Feb. 8, 2024 | IMRX | A | 244,286 | · | · | 244,286 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 8, 2024 | IMRX | A | 16,414 | · | · | 16,414 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2023 | IMRX | A | 352,244 | · | · | 352,244 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2023 | IMRX | A | 21,756 | · | · | 374,000 Direct | +6.18% | Acquired | (price as of 2026-10-05) |
| Dec. 22, 2022 | IMRX | M | 2,500 | $3.01 | $7,525 | 2,261,852 Direct | +0.11% | Acquired | 34.2% (price as of 2026-10-05) |
| Dec. 22, 2022 | IMRX | M | 2,500 | · | · | 203,500 Direct | -1.21% | Disposed | (price as of 2026-10-05) |
| April 12, 2022 | IMRX | M | 2,000 | $3.01 | $6,020 | 2,259,352 Direct | +0.09% | Acquired | 34.2% (price as of 2026-10-05) |
| April 12, 2022 | IMRX | M | 2,000 | · | · | 206,000 Direct | -0.96% | Disposed | (price as of 2026-10-05) |
| March 23, 2022 | IMRX | P | 3,000 | $8.02 | $24,060 | 2,257,352 Direct | +0.13% | Acquired | -49.6% (price as of 2026-10-05) |
| Feb. 28, 2022 | IMRX | M | 2,000 | $3.01 | $6,020 | 2,254,352 Direct | +0.09% | Acquired | 34.2% (price as of 2026-10-05) |
| Feb. 28, 2022 | IMRX | M | 2,000 | · | · | 208,000 Direct | -0.95% | Disposed | (price as of 2026-10-05) |
| Feb. 10, 2022 | IMRX | A | 156,485 | · | · | 156,485 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 10, 2022 | IMRX | A | 45,615 | · | · | 202,100 Direct | +29.15% | Acquired | (price as of 2026-10-05) |
| Sept. 13, 2021 | IMRX | P | 2,083 | $22.87 | $47,638 | 2,602,352 Direct | +0.08% | Acquired | -82.3% (price as of 2026-10-05) |
| Aug. 3, 2021 | IMRX | C | 8,171 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Aug. 3, 2021 | IMRX | C | 40,928 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Aug. 3, 2021 | IMRX | P | 2,098 | $15.00 | $31,470 | 2,600,269 Direct | +0.08% | Acquired | -73.1% (price as of 2026-10-05) |
| Aug. 3, 2021 | IMRX | C | 49,099 | · | · | 2,598,171 Direct | +1.93% | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | IMRX | Stock Option | Class A Common Stock | $4.91 | Feb. 3, 2036 | 688,000 | Acquired |
| Feb. 5, 2025 | IMRX | Stock Option | Class A Common Stock | $1.91 | Feb. 5, 2035 | 480,000 | Acquired |
| Feb. 8, 2024 | IMRX | Stock Option | Class A Common Stock | $6.09 | Feb. 8, 2034 | 244,286 | Acquired |
| Feb. 8, 2024 | IMRX | Stock Option | Class A Common Stock | $6.70 | Feb. 8, 2029 | 16,414 | Acquired |
| Feb. 15, 2023 | IMRX | Stock Option | Class A Common Stock | $4.25 | Feb. 15, 2033 | 352,244 | Acquired |
| Feb. 15, 2023 | IMRX | Stock Option | Class A Common Stock | $4.68 | Feb. 15, 2028 | 21,756 | Acquired |
| Dec. 22, 2022 | IMRX | Stock Option | Class A Common Stock | $3.01 | Dec. 15, 2029 | 2,500 | Disposed |
| April 12, 2022 | IMRX | Stock Option | Class A Common Stock | $3.01 | Dec. 15, 2029 | 2,000 | Disposed |
| Feb. 28, 2022 | IMRX | Stock Option | Class A Common Stock | $3.01 | Dec. 15, 2029 | 2,000 | Disposed |
| Feb. 10, 2022 | IMRX | Stock Option | Class A Common Stock | $9.66 | Feb. 9, 2032 | 156,485 | Acquired |
| Feb. 10, 2022 | IMRX | Stock Option | Class A Common Stock | $10.63 | Feb. 9, 2027 | 45,615 | Acquired |
| Aug. 3, 2021 | IMRX | Series B Preferred Stock | Class A Common Stock | · | · | 8,171 | Disposed |
| Aug. 3, 2021 | IMRX | Series A Preferred Stock | Class A Common Stock | · | · | 40,928 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 29, 2021 | IMRX | Class A Common Stock | 2,549,072 | Direct |
| July 29, 2021 | IMRX | Class A Common Stock | 544,927 | Indirect |
| July 29, 2021 | IMRX | Stock Option | 210,000 | Direct |
| July 29, 2021 | IMRX | Stock Option | 175,000 | Direct |
| July 29, 2021 | IMRX | Series A Preferred Stock | 40,928 | Direct |
| July 29, 2021 | IMRX | Series B Preferred Stock | 8,171 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $641,493 | $423,385 | · | $579,504 | · | · | $16,230 | $1,660,612 |
| 2024 | $616,820 | $308,410 | · | $1,003,776 | · | · | $16,086 | $1,945,092 |
| 2023 | $593,096 | $326,203 | · | $983,116 | · | · | $15,786 | $1,918,201 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.